Tracon Pharmaceuticals, Inc.·4

Mar 13, 5:56 PM ET

THEUER CHARLES 4

4 · Tracon Pharmaceuticals, Inc. · Filed Mar 13, 2024

Insider Transaction Report

Form 4
Period: 2024-03-12
THEUER CHARLES
DirectorPresident and CEO
Transactions
  • Award

    Common Stock

    2023-04-20$0.14/sh+3,500$482402,917 total
  • Award

    Common Stock

    2023-10-20$0.13/sh+3,500$467406,417 total
  • Award

    Employee Stock Option (Right to Buy)

    2024-03-12+518,300518,300 total
    Exercise: $0.39Exp: 2034-03-11Common Stock (518,300 underlying)
Footnotes (3)
  • [F1]Shares acquired by the Reporting Person under the Issuer's 2015 Employee Stock Purchase Plan on April 20, 2023.
  • [F2]Shares acquired by the Reporting Person under the Issuer's 2015 Employee Stock Purchase Plan on October 20, 2023.
  • [F3]1/4th of the shares subject to this option shall vest on the first anniversary of the Grant Date shown in column 3 above. The remaining shares vest and become exercisable in 36 equal monthly installments thereafter, on the last day of each month.

Documents

1 file
  • 4
    form4-03132024_090306.xmlPrimary